EHE International Selects Project A.L.S. To Raise Awareness For Brain Disease Epidemic
Rockefeller Plaza Exhibit Highlights Hope for the Growing Health Concern
NEW YORK, April 2, 2013 /PRNewswire/ -- As the leader for research in ALS, the devastating brain disorder also known as Lou Gehrig's disease, Project A.L.S. has been selected by EHE International to raise awareness about ALS and related brain diseases in a 103-square foot window display in Rockefeller Plaza. The interactive Project A.L.S. exhibit debuts today in the major international thoroughfare, and will be available to the public for the month of April.
The participatory exhibit focuses on ALS, Alzheimer's, Parkinson's and the closely related brain diseases that will affect 1 in 25 Americans by the year 2020. Scientists agree that if we can understand and treat ALS, we will have new insight into cures for the range of brain diseases. The display window, donated by EHE International, highlights the growing epidemic of brain disease by literally giving viewers a window into the human brain with information about brain disease and opportunities for visitors to participate in stopping its spread.
"People need to realize that brain disease is going to touch each one of us," said Project A.L.S. President and Co-Founder Meredith Estess. "Project A.L.S. is grateful to EHE International for the opportunity to educate the public on a problem that has grown to an epidemic of devastating proportions."
Throughout the month of April, the state-of-the-art exhibit will provide the opportunity for viewers to learn about, participate in, and donate to life-saving Project A.L.S. research. Visitors will interact with the three-dimensional exhibit via eye-popping design elements, a QR code, and perhaps most dramatically, the stark and stunning facts about the prevalence of brain disease in the 21st century.
"EHE International is proud to support Project A.L.S. by offering the Rockefeller Plaza window to raise public awareness and education about ALS," said Deborah McKeever, President of EHE International.
Since 1913, EHE International has been the recognized leader in preventive medicine. Its clinical protocols are specifically designed for the early detection of preventable disease and its associated risk factors, supported by robust personal coaching and wellness tools and resources, and its industry leading educational and social engagement platforms. The company is well-known for its corporate-sponsored employee benefit, "EHE & Me," a patient-centered approach to preventive care and life-style management programs specifically designed for integration into self-funded employer-sponsored medical plans.
For more information, contact EHE International, 10 Rockefeller Plaza, 4th Floor, New York, NY 10020; 212-332-3700; www.EHEandMe.com.
Project A.L.S.™ is a non-profit 501©3 devoted to understanding, treating, and ultimately curing ALS, also known as Lou Gehrig's disease. Founded in 1998 by Jenifer Estess, her family and friends, Project A.L.S. has raised more than $67 million and become the new paradigm for brain disease research. ALS is a devastating neurodegenerative disease that, combined with the closely related Parkinson's and Alzheimer's diseases, is a 21st century epidemic. In five years 1 in 25 Americans will be affected with a neurodegenerative disease.
For more information, contact Project A.L.S., 801 Riverside Drive #6G, New York, NY 10032; 212-420-7382; www.projectals.org.
ALS, also known as Lou Gehrig's disease and motor neuron disease, is a fatal neurodegenerative disease that affects adults of all ages. ALS targets large brain cells residing in the brain and along the spinal cord called motor neurons. In ALS, as motor neurons get sick and die, a person progressively loses the ability to move: to walk, speak, swallow, and breathe. ALS is usually fatal within 2-5 years of diagnosis.
SOURCE Project A.L.S.
More by this Source
Project A.L.S. Announces Research Effort With Lilly
Nov 19, 2013, 09:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.